Synthetic Lethal Therapy for KRAS Mutant Non-small-cell Lung Carcinoma with Nanoparticle-mediated CDK4 siRNA Delivery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthetic Lethal Therapy for KRAS Mutant Non-small-cell Lung Carcinoma with Nanoparticle-mediated CDK4 siRNA Delivery

Published:2014-05 Issue:5 Volume:22 Page:964-973
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Mao Cheng-Qiong,Xiong Meng-Hua,Liu Yang,Shen Song,Du Xiao-Jiao,Yang Xian-Zhu,Dou Shuang,Zhang Pei-Zhuo,Wang Jun

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma;Travis;J Thorac Oncol,2011

4. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

5. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK4/6 inhibitors in lung cancer: current practice and future directions;European Respiratory Review;2024-01-31

2. Recent advances in the development of inhibitors targeting KRAS-G12C and its related pathways;European Journal of Medicinal Chemistry;2023-11

3. Cationic Polymers as Transfection Reagents for Nucleic Acid Delivery;Pharmaceutics;2023-05-15

4. Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases;Acta Pharmaceutica Sinica B;2023-04

5. Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C;Cancer Discovery;2022-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3